TITLE III U.K. MARKETING AUTHORISATION PROCEDURES

F1 CHAPTER 2 U.K. Paediatric use marketing authorisation

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Textual Amendments applied to the whole legislation

F1 Regulation revoked (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), Sch. 9 para. 1(l) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)